Relation Between Insulin Antibody and Complement-Fixing Islet Cell Antibody at Clinical Diagnosis of IDDM
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
To test the hypothesis that insulin-binding antibodies (IBAs) appearing in the circulation before insulin treatment are markers of β-cell damage, we studied the prevalence of IBAs and both conventional (IF-ICAs)- and complement (CF-ICAs)-fixing cytoplasmic islet cell antibodies in 60 newly diagnosed diabetic children with a mean age of 9.5 yr. Seventeen (28.3%) had an insulin binding exceeding the upper range (2.8%) of that observed in 68 age-matched controls. The IBA-positive subjects were characterized by a younger age of onset [6.2 ± 4.0 (SD) vs. 10.8 ± 3.2 yr; P < 0.001], lower glycosylated hemoglobin A, levels (14.1 ± 3.1 vs. 16.0 ± 3.0%; P < 0.05), lower serum C-peptide concentrations (0.12 ± 0.07 vs. 0.20 ± 0.17 nmol/L; P < 0.05), and an increased frequency of HLA-Dw4 (9/13 vs. 11/37; P < 0.05). There was no significant relation between IBAs and serum C-peptide concentrations after age adjustment by multiple regression analysis. Forty-three children (75%) were positive for IF-ICA and 38 (63.3%) for CF-ICA. Twelve IBA-positive diabetics (70.6%) had IFICA as well as CF-ICA in their serum. No association could be observed between IBA and either IF-ICA or CF-ICA, however. The results suggest that IBAs developing before diagnosis serve as an indicator of clinical and genetic heterogeneity within IDDM rather than as a marker of autoimmune β-cell destruction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin antibodies in insulin-dependent diabetics before insulin treatment
Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K., & Paquette, T. L. (1983) · Science · doi:10.1126/science.6362005 · Cited by 1,078
Cited by
Biochemical markers of type 1 diabetes: clinical use
Pozzilli, S. M. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655101753352031 · Cited by 311
A Comparison of Childhood and Adult Type I Diabetes Mellitus
Karjalainen, J., Salmela, P., Ilonen, J., Surcel, H.-M., & Knip, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201401 · Cited by 279
Self-citationGenetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes.
Sabbah, E., Savola, K., Ebeling, T., Kulmala, P., Vähäsalo, P., Ilonen, J., Salmela, P. I., & Knip, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1326 · Cited by 219
Self-citationVaarala, O., Knip, M., Paronen, J., Hämäläinen, A. M., Muona, P., Väätäinen, M., Ilonen, J., Simell, O., & Akerblom, H. K. (1999) · Diabetes · doi:10.2337/diabetes.48.7.1389 · Cited by 182
Self-citationHolmberg, H., Vaarala, O., Sadauskaitė – Kuehne, V., Ilonen, J., Padaiga, Ž., & Ludvigsson, J. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.10.022 · Cited by 35
Self-citation
Metadata
- Authors
- Karjalainen, J., Knip, M., Mustonen, A., Ilonen, J., & Åkerblom, H. K.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1986-05-01
- Volume
- 35
- Issue
- 5
- Pages
- 620-622
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2144990534
- Cited by
- 64
- References
- 1
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relation Between Insulin Antibody and Complement-Fixing Islet Cell Antibody at Clinical Diagnosis of IDDM. https://app.cochat.ai/papers/10.2337/diab.35.5.620
- The paper
- Karjalainen, J., Knip, M., Mustonen, A., Ilonen, J., & Åkerblom, H. K. (1986). Relation Between Insulin Antibody and Complement-Fixing Islet Cell Antibody at Clinical Diagnosis of IDDM. Diabetes. https://doi.org/10.2337/diab.35.5.620
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.